Duke Center for Precision Health Awards Pilot Funding to Advance Genomic Science
The Duke Center for Precision Health and Precision Genomics Collaboratory have awarded five pilot grants to advance genomic science at Duke by leveraging and enhancing the OneDukeGen study infrastructure.
READI Impact Report: Improving Health Through Research and Community Partnerships
We proudly present the READI Impact Report highlighting the activities and milestones that helped to achieve our vision to improve health and health equity for all.
Celebrating Hispanic Heritage Month
As we prepare to celebrate Hispanic Heritage Month, which runs from Sept. 15 to Oct.
SEED Health Atlas Tracks Social Determinants of Health in Durham, Beyond
Taking a close look at data from 150 neighborhoods in Durham County, researchers from the Duke University School of Medicine and Icahn School of Medicine at Mt.
Bentley-Edwards Traces Maternal Mortality Gap to Slavery-era Exploitation
In an article in the Charlotte Post, Keisha Bentley-Edwards, PhD, co
Cannabis and Tobacco Use on the Rise, Especially Among Older Adults
The number of Americans using both cannabis and tobacco is increasing, with a particular surge among older adults, according to a new study by researchers at Duke University School of Medicine and Duke CTSI who analyzed two decades of national data. Their findings show that combined use of cannabis and tobacco poses greater health risks than using either substance alone.
Duke-NCCU Bridge Office Students Celebrate Clinical Research Internship Experiences
The Duke-North Carolina Central University (NCCU) Bridge Office student interns celebrated the conclusion of their summer internships Aug. 1 at a closing ceremony.
Kimberly Johnson, Chris Lindsell Assume New Roles at CTSI
The Duke Clinical and Translational Science Institute (CTSI) announces that Kimberly S. Johnson, MD, MHS, and Chris Lindsell, PhD, have been named chief equity officer and director of CTSI Biostatistics and Bioinformatics, respectively.
COVID Vaccination Not Associated with Kidney Disease in Black Adults at High Risk
Using data from community studies based at Duke Kannapolis, researchers found that COVID vaccination was not associated with new onset of APOL1-related kidney disease in African American adults who were at high risk for the condition.
Duke Launches New Clinical Trials Website and Directory
Duke University School of Medicine, in partnership with the Duke Clinical and Translational Science Institute (CTSI) and the Duke Office of Clinical Research (DOCR), has launched a new community-facing website about clinical research.